下载全文

Preclinical pharmacodynamic evaluation of a new Src/FOSL1 inhibitor, LY-1816, in pancreatic ductal adenocarcinoma

Yang, Wei; Meng, Lingwei; Chen, Kai; Tian, Chenyu; Peng, Bing; Zhong, Lei; Zhang, Chunhui; Yang, Xin; Zou, Jun; Yang, Shengyong; Li, Linli^*

CANCER SCIENCE, 2019, 110(4): 1408-1419.

赞(1) 收藏 分享 浏览

下载全文

Structural optimization and structure-activity relationship studies of N-phenyl-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-amine derivatives as a new class of inhibitors of RET and its drug resistance mutants

Yang, Jiao; Chen, Kai; Zhang, Guo; Yang, Qiu-Yuan; Li, Yue-Shan; Huang, Shen-Zhen; Wang, Yan-Lin; Yang, Wei; Jiang, Xiao-Juan; Yan, Heng-Xiu; Zhu, Jing-Qiang; Xiang, Rong; Luo, You-Fu; Li, Wei-Min; Wei, Yu-Quan; Li, Lin-Li^*; Yang, Sheng-Yong^*

European Journal of Medicinal Chemistry, 2018, 143: 1148-1164.

赞(1) 收藏 分享 浏览

下载全文

From Lead to Drug Candidate: Optimization of 3-(Phenylethyny1)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as Agents for the Treatment of Triple Negative Breast Cancer

Zhang, Chun-Hui; Chen, Kai; Jiao, Yan; Li, Lin-Li; Li, Ya-Ping; Zhang, Rong-Jie; Zheng, Ming-Wu; Zhong, Lei; Huang, Shen-Zhen; Song, Chun-Li; Lin, Wan-Ting; Yang, Jiao; Xiang, Rong; Peng, Bing; Han, Jun-Hong; Lu, Guang-Wen; Wei, Yu-Quan; Yang, Sheng-Yong^*

Journal of Medicinal Chemistry, 2016, 59(21): 9788-9805.

赞(1) 收藏 分享 浏览

下载全文

Preclinical Evaluation of a Novel Orally Available SRC/Raf/VEGFR2 Inhibitor, SKLB646, in the Treatment of Triple-Negative Breast Cancer

Zheng, Ming-Wu; Zhang, Chun-Hui; Chen, Kai; Huang, Mei; Li, Ya-Ping; Lin, Wan-Ting; Zhang, Rong-Jie; Zhong, Lei; Xiang, Rong; Li, Lin-Li; Liu, Xin-Yu; Wei, Yu-Quan; Yang, Sheng-Yong^*

Molecular Cancer Therapeutics, 2016, 15(3): 366-378.

赞(1) 收藏 分享 浏览